Using technology to support diabetes care in hospital: Guidelines from the Joint British Diabetes Societies for Inpatient Care (JBDS‐IP) group and Diabetes Technology Network (DTN) UK

Joint British Diabetes Societies for Inp… · 2024 · United Kingdom

Source and licence

Authors
Parizad Avari, Pratik Choudhary, Alistair Lumb et al.
Title
Using technology to support diabetes care in hospital: Guidelines from the Joint British Diabetes Societies for Inpatient Care (JBDS‐IP) group and Diabetes Technology Network (DTN) UK
Journal
Diabetic Medicine, 2024
Licence
CC BY 4.0
Changes
Verbatim excerpts; formatting adapted

Full text retrieved 2026-10-27 from Europe PMC · PMC11823341

Licence statement of the original publication

This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

This page reproduces excerpts of the original publication; the original is authoritative. It has not been reviewed by a physician, does not state a recommendation of Medelix and does not replace medical advice. The guideline may have been updated since.

Open the original publication →Full text on Europe PMC

Recommendations

We found no explicitly labelled recommendations in this publication; its recommendations are in the running text of the original.

Abstract

This article summarises the Joint British Diabetes Societies for Inpatient Care (JBDS‐IP) Group guidelines on the use of technology to support diabetes care in hospital. The guideline incorporates two main areas: (i) use of wearable technology devices to improve diabetes management in hospital (including continuous glucose monitoring and insulin pump therapy) and (ii) information technology. Although it is reasonable to extrapolate from the evidence available, that devices developed to enhance diabetes care outside hospital will show similar benefits, there are challenges posed within the inpatient setting in hospital. This guidance provides a pragmatic approach to supporting self‐management in individuals using wearable technology admitted to hospital. Furthermore, it also aims to provide a best practice guide for using information technology to monitor diabetes care and communicate between health professionals.

Contents of the original publication

The section headings of the original.

  • INTRODUCTION
  • WEARABLE DIABETES TECHNOLOGY
  • Continuous glucose monitoring
  • Hybrid closed‐loop systems/automated insulin delivery systems
  • ELECTRONIC PRESCRIBING AND MEDICINES ADMINISTRATION
  • CLINICAL USE OF POINT‐OF‐CARE TESTING
  • Point‐of‐care glucose measurements
  • Using networked POCT measurements to drive clinical effectiveness
  • INFORMATION TECHNOLOGY TO SUPPORT INPATIENT DIABETES CARE
  • Electronic health records
  • SELF‐MANAGEMENT PROTOCOLS
  • Self‐management of insulin pumps (continuous subcutaneous insulin infusion during hospital admission)
  • Principles of self‐management of insulin pumps by inpatients
  • Pump management for procedures requiring a period of starvation
  • Continuous glucose monitoring
  • Electronic prescribing and medicines administration
  • NATIONAL DATASETS TO IMPROVE DIABETES CARE
  • FUTURE RESEARCH
  • ADDITIONAL WEBSITE LINKS

A question about this guideline?

Medelix answers clinical questions from guidelines and studies – every statement with its source.

Are you the rights holder and object to this reproduction? Write to contact@medelix.ai and we will take the page down promptly. Imprint